Perinatal characteristics in relation to incidence of and mortality from prostate cancer

British Medical Journal

Volumn 313, Issue 7053, 1996, Pages 337-341

  Ekbom, Anders ^a   Hsieh, Chung Cheng ^b   Lipworth, Loren ^c   Wolk, Alicja ^a   Pontén, Jan ^a   Adami, Hans Olov ^a   Trichopoulos, Dimitrios ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c HARVARD CENTER FOR CANCER PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; HORMONE;

ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CANCER MORTALITY; CARCINOGENESIS; CONTROLLED STUDY; ECLAMPSIA; GESTATIONAL AGE; HUMAN; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MENARCHE; PARITY; PERINATAL PERIOD; PLACENTA WEIGHT; PREECLAMPSIA; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROSTATE CANCER; SOCIAL CLASS;

EID: 0029810907     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.313.7053.337     Document Type: Article

References (47)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA 1995;45:8-30.
3. Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst 1990;82:1624-8.
4. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J, eds. Cancer incidence in five continents. Vol 6. Lyons, France: International Agency for Research on Cancer, 1992. (IARC scientific publication No 120.)
5. Lipworth L. Epidemiology of breast cancer. Eur J Cancer Prev 1995;4:7-30.
6. Tomatis L, ed. Cancer: Causes, occurrence and control. Lyon, France: International Agency for Research on Cancer, 1990. (IARC scientific publication No 100.)
7. Andersson S-O, Baron J, Wolk A, Lindgren C, Berstrom R, Adami H-O. Early life risk factors for prostate cancer: a population-based case-control study in Sweden. Cancer Epidemiol Biomark Prev 1995;4:187-92.
8. Rotkin ID. Studies of the epidemiology of prostatic cancer: expanded sampling. Cancer Treat Rep 1977;61:173-80.
9. Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer 1988;57:216-8.
10. Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet 1990;335:939-40.
11. Ekbom A, Thurfjell E, Hsieh CC, Trichopoulos D, Adami HO. Perinatal characteristics and adult mammographic patterns. Int J Cancer 1995;61:177-80.
12. Ross RD, Henderson BE. Do diet and androgens alter prostate cancer via a common etiologic pathway? J Natl Cancer Inst 1994;86:252-4.
13. Tibblin G, Eriksson M, Cnattingius S, Ekbom E. High birth weight as a predictor of prostate cancer risk. Epidemiology 1995;6:423-4.
14. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 1994;54:5059-63.
15. Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
16. Trichopoulos D, Lipworth L. Is cancer causation simpler than we thought, hut more intractable? Epidemiology 1995;6:347-9.
17. Lunde AS, Lundeborg S, Lettenstrom GS, Thugesen L, Huebner J. The person-number systems of Sweden, Norway, Denmark and Israel. Vital Health Stat [2] 1980;84:5-11.
18. Cancer Registry. Cancer incidence in Sweden 1987. Stockholm: National Board of Health and Welfare, 1990.
19. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980 (IARC scientific publication No 32.)
20. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 1966;37:403-8.
21. Daikoku NH, Johnson JWC, Graf C, Kearney K, Tyson JE, King TM. Patterns of intrauterine growth retardation. Obstet Gynecol 1979;54:211-9.
22. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC, et al. A prospective study of dietary tat and risk of prostate cancer. J Natl Cancer Inst 1993;85:1571-9.
23. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87:652-61. Hayes RB. Are dietary fat and vasectomy risk factors for prostate cancer? J Natl Cancer Inst 1995;87:629-31.
24. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87:652-61. Hayes RB. Are dietary fat and vasectomy risk factors for prostate cancer? J Natl Cancer Inst 1995;87:629-31.
25. John EM, Whittemore AS, Wu AH, Kolonel LN, Hislop TG, Howe GR, et al. Vasectomy and prostate cancer: results from a multiethnic case-control study. J Natl Cancer Inst 1995;87:662-69.
26. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 1993;269:873-7.
27. Thune I, Lund E. Physical activity and the risk of prostate and resticular cancer: a cohort study of 53 000 Norwegian men. Cancer Causes Control 1994;5:549-56.
28. Coffey DS, Isaacs JT. Control of prostate growth. Urology 1981;17 (Suppl 3):17-24.
29. Greenwald P. Prostate. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. Philadelphia: Saunders, 1982:9138-46.
30. Barrett-Connor E, Garland C, McPhillips JB, Khaw KT, Wingard DL. A prospective, population-based study of androstenedione, estrogens and prostatic cancer. Cancer Res 1990;50:169-73.
31. Hsing A, Comstock G. Serum hormone and risk of subsequent prostate cancer. Am J Epidemiol 1989;130:829.
32. Drafta D, Proca E, Zamfir V, Schindler AE, Neacsu E, Stroe E. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate. J Steroid Biochem 1982;17:689-93.
33. Andersson SO, Adami HO, Bergstrom R, Wide L. Serum pituitary and sex steroid hormone levels in the aetiology of prostatic cancer - a population-based case-control study. Br J Cancer 1993;68:97-102.
34. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992;339:887-9.
35. Klopper A, Jandial V, Wilson G. Plasma steroid assay in the assessment of foetoplacental function. J Steroid Biochem 1975;6:651-6.
36. McFadyen IR, Worth HG, Wright DJ, Norta SS. High oestrogen excretion in pregnancy. Br J Obstet Gynaecol 1982;89:994-9.
37. Gerhard I, Vollmar B, Runnebaum B, Klilnga K, Haller U, Kubli F. Weight percentile at birth. II. Prediction by endocrinological and sonographic measurements. Eur J Obstet Gynecol Reprod Biol 1987;26:313-28.
38. Petridou E, Panagiotopoulou K, Katsouyanni K, Spanos E, Trichopoulos D. Tobacco smoking, pregnancy estrogens and birth weight. Epidemiology 1990;1:247-50.
39. Long PA, Abell DA, Beischer NA. Fetal growth and placental function assessed by urinary estriol excretion before the onset of pre-eclampsia. Am J Obstet Gynecol 1979;135:344-7.
40. Rosing U, Carlstrom K. Serum levels of unconjugated and total estrogens and dehydroepiandrosterone, progesterone and urinary estriol excretion in pre-eclampsia. Gynecol Obstet Invest 1984;18:199-205.
41. Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE. Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 1986;76:1035-9.
42. Panagiotopoulou K, Katsouyanni K, Petridou E, Garas Y, Tzonou A, Trichopoulos D. Maternal age, parity and pregnancy estrogens. Cancer Causes Control 1990;1:119-24.
43. Nomura AMY, Kolonel LN. Prostate cancer: a current perspective. Am J Epidemiol 1991;13:200-27.
44. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9.
45. Wang X, Guyer B, Paige DM. Differences in gestational age-specific birthweight among Chinese, Japanese and White Americans. Int J Epidemiol 1994;23:119-28.
46. Sakr WA, Haas GP, Cassin BF, Pontes FE, Crissman JD. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-85.
47. Cheville JC, Bostwick DG. Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma. Am J Surg Pathol 1995;19:1068-76.